Neuromodulation of pharyngeal nerves to treat diseases
US-2024366279-A1 · Nov 7, 2024 · US
US2018228533A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018228533-A1 |
| Application number | US-201815952985-A |
| Country | US |
| Kind code | A1 |
| Filing date | Apr 13, 2018 |
| Priority date | Jun 14, 2011 |
| Publication date | Aug 16, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Systems and methods for treating a patient's mucus hypersecretion condition are disclosed herein. Certain implementations may involve a method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough. The method may include advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient. The treatment delivery portion may contact mucosal tissue of the upper airway without piercing the mucosal tissue. The treatment delivery portion may deliver treatment to at least one tissue selected from the group of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the at least one tissue and thus treat at least one of post nasal drip or chronic cough in the patient.
Opening claim text (preview).
What is claimed is: 1 . A method for deactivating a target tissue in an airway of a patient to reduce mucus secretion, the method comprising: advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient; contacting a surface of a mucosal tissue of the airway with the treatment delivery portion, without piercing the surface of the mucosal tissue; and delivering an energy-based treatment from the treatment delivery portion to a selected tissue depth to deactivate the target tissue underlying the mucosal tissue and thus reduce mucus secretion. 2 . The method of claim 1 , wherein the target tissue comprises nerve tissue, and wherein delivering the energy-based treatment comprises ablating the nerve tissue. 3 . The method of claim 2 , wherein the nerve tissue comprises the sphenopalatine ganglion. 4 . The method of claim 1 , wherein the target tissue is selected from the group consisting of cilia, goblet cells, and submucosal tissue. 5 . The method of claim 1 , wherein delivering the energy-based treatment comprises delivering energy in a form selected from the group consisting of ultrasound, microwave, heat, radiofrequency, electrical, light, and laser energy. 6 . The method of claim 5 , wherein delivering the energy-based treatment comprises delivering radiofrequency energy from a first electrode on a tissue contact surface of the treatment delivery portion across a convex portion of the tissue contact surface to a second electrode on the tissue contact surface. 7 . The method of claim 6 , wherein the first electrode and the second electrode comprise non-piercing bumps on the tissue contact surface, and wherein contacting the surface of the mucosal tissue comprises contacting the non-piercing bumps on the tissue contact surface with the surface of the mucosal tissue. 8 . The method of claim 1 , further comprising: measuring an amount of delivered energy using a thermocouple on the treatment delivery portion; and adjusting the amount of delivered energy by adjusting a setting of the treatment delivery portion. 9 . The method of claim 1 , wherein delivering the energy-based treatment comprises applying cryotherapy. 10 . The method of claim 9 , wherein the target tissue comprises nerve tissue, and wherein applying the cryotherapy comprises ablating the nerve tissue. 11 . The method of claim 1 , further comprising applying force against the surface of the mucosal tissue with the treatment delivery portion to mechanically alter a shape of the airway while delivering the energy-based treatment.
multiple needles · CPC title
being one or more injection needles · CPC title
having a short rigid shaft for accessing the inner body through natural openings · CPC title
Probes or electrodes therefor · CPC title
Balloons · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.